NCTA Webinar Series
Overview:President Trump’s recent Executive Order to reschedule marijuana from a Schedule I substance (no legitimate medical use) to a Schedule III substance has significant implications for employers—especially those regulated by the Department of Transportation (DOT).
Schedule III drugs have accepted medical uses and a moderate to low potential for physical or psychological dependence. Examples include products containing limited quantities of codeine (such as Tylenol with codeine), anabolic steroids, and ketamine.
Why This Matters:This change raises important questions for DOT-regulated employers and those managing non-DOT testing programs. Join us for a concise, informative session that will provide the latest guidance and practical steps to keep your programs compliant.
Key Takeaways:
Date & Time:
Thursday, January 29th 10:00 AM
Speaker:Kim ClaytorCompliance Director / Sales ManagerFleetSafe Solutions
Who Should Attend:NCTA members responsible for compliance, HR, or safety programs.
Register Now to ensure you have the most up-to-date information and actionable guidance.
If you have questions regarding this event, please contact Laura Sherman at lsherman@nctrucking.com.
You must be a member of the NCTA to participate.
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Create an Account
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}